7 min read
Filed by: Tenisha Manning, Founder – CW Alliance
What's happening:
A test is ordered. A finding appears. The provider tells you to "monitor it" or "watch and wait." You're reassured that it's probably nothing serious. But no timeline is set. No specific plan is documented. You're told to return "if symptoms change" or "as needed." You leave without clarity on when you should come back. Whether the provider will call you with results. Whether you should check the portal. Whether you're actually being monitored or whether you've been left to drift.
Why it matters:
Watch-and-wait can be an appropriate medical strategy—for slow-growing conditions, early findings that may resolve, situations where intervention carries risk. But watch-and-wait without a defined plan is not medicine. It's abandonment dressed up as reassurance. A strategy without a timeline is not a strategy. It's a gap. And gaps are where disease progresses.
What to do differently:
When a provider recommends watch-and-wait, demand specificity. When will you return? What tests will be repeated? What changes in your symptoms would warrant urgent contact? Who will contact you with results? What is the timeframe? Get the plan in writing. Document it in your medical record. If the plan is vague, push back. A defined follow-up plan is not optional. It is the minimum standard of care.
You feel a lump. You go for imaging. A mammogram is ordered. An ultrasound is performed.
The findings come back. There's a nodule. The radiologist's report recommends a biopsy. It also recommends follow-up in three months.
You see a breast surgeon. She examines you. She feels the same nodule you felt. She tells you the findings are probably benign. She gives you a choice: You can have a biopsy now, or you can follow up in three months with repeat imaging.
No preference is stated. No urgency is conveyed. Just a choice. As if both options are equally valid.
You choose to wait. To follow up in three months.
Three months pass. But before you can get your follow-up appointment, the country shuts down. COVID-19. Offices close. Appointments are cancelled. You call to reschedule. The earliest available appointment is eight months away.
Eight months pass.
You finally get your follow-up imaging. The nodule is still there. It hasn't resolved. It looks suspicious now. A biopsy is ordered immediately.
The biopsy confirms breast cancer. Stage 1B.
You could have known this eight months earlier. You could have had treatment started eight months earlier. The cancer could have been caught before it progressed. But there was no defined follow-up plan. No timeline. No clear ownership of your care. Just a vague recommendation to "follow up" that drifted into eight months of delay.
The signal: You were told to wait. But no one told you for how long. No one told you who would contact you. No one documented a plan. And in the absence of a plan, eight months passed.
What happens when watch-and-wait has no defined plan:
A finding is discovered. A provider recommends monitoring rather than immediate intervention. This is often appropriate. Slow-growing cancers, benign-appearing nodules, early findings that may resolve—these situations call for watchful waiting.
But watchful waiting requires a plan. A timeline. Specific repeat testing. Clear ownership of follow-up. A way for the patient to know when to return and what to expect.
When these elements are absent, watch-and-wait becomes drift. The patient is left uncertain. The provider assumes the patient will call if symptoms change. The patient assumes the provider will contact them with a follow-up plan. Neither happens. Months pass. The condition progresses. The delayed diagnosis becomes inevitable.
The pattern across cases:
When watch-and-wait lacks a defined plan:
The patient is told to "monitor" or "follow up" without a timeline
No repeat testing schedule is documented
No clear contact plan is established
The patient doesn't know who will reach out or when
The provider doesn't document ownership of follow-up
Months pass without contact
The patient eventually returns (or is seen incidentally) and disease has progressed
Delayed diagnosis results
When watch-and-wait has a defined plan:
The patient knows exactly when to return
Repeat testing is scheduled in advance
The provider documents what symptoms would warrant urgent contact
Clear ownership is assigned (provider, patient, or both)
Follow-up happens as planned
Early disease progression is caught
Timely intervention occurs
The difference between appropriate monitoring and negligent delay is the plan.
Proverbs 29:18 teaches: "Where there is no vision, the people cast off restraint; but blessed is he who keeps the law." Without a clear vision of what comes next—without a defined plan—patients are left adrift. They cannot restrain themselves to a schedule they don't know. They cannot prepare for a follow-up they don't understand. Vision is not optional. A plan is not optional.
Yogi Berra observed: "If you don't know where you are going, you'll end up someplace else." Watch-and-wait without a defined plan leaves the patient with no destination. No timeline. No next step. The patient drifts. Disease progresses. And by the time the patient realizes where they've ended up, it's too late.
Research on delayed diagnosis shows that failure to follow up on abnormal findings is a leading cause of delayed cancer diagnosis. One documented case illustrates this pattern: A woman at high risk for breast cancer felt a lump and underwent mammography and ultrasound in December 2019. The imaging showed a nodule. The radiologist's report recommended biopsy and follow-up in three months. The patient then saw a breast surgeon who also felt the nodule and told the patient she could either have a biopsy or follow up in three months—with no clear preference stated for either option. The patient chose to wait. She was given no specific follow-up appointment, no written plan, no documentation of when she should return. Before the three-month follow-up could occur, COVID-19 restrictions closed offices. When she finally was able to obtain a follow-up appointment eight months later, the imaging showed the nodule was suspicious. Biopsy confirmed Stage 1B breast cancer. The eight-month delay—attributable directly to the absence of a defined follow-up plan—resulted in disease progression and a settlement for $9 million. Medical experts testified that had the patient been diagnosed eight or nine months earlier, she would have had less cancer and better overall chances of survival.
Research on watch-and-wait strategies in cancer care shows that when this approach is used appropriately with clear protocols, it can be safe and effective. However, studies also document that watch-and-wait without defined timelines, specific repeat testing schedules, and clear communication about follow-up creates significant risk. Patients report anxiety, confusion about when to return, and uncertainty about whether they are actually being monitored. Healthcare systems report that vague follow-up recommendations lead to missed appointments, lost records, and gaps in care.
The difference between watchful waiting and negligent delay is documentation. Specificity. A plan.
Why Watch-and-wait Drifts Without A Plan
Let me explain what's happening structurally.
Providers assume patients will remember and initiate follow-up.
A provider recommends follow-up in three months. The provider assumes the patient will remember this conversation. Will mark the calendar. Will call to schedule. Will show up. But patients are managing multiple conditions, multiple providers, multiple pieces of information. A verbal recommendation drifts into the background. Months pass.
The system has no mechanism to track pending follow-up.
In many healthcare systems, there is no automated reminder system. No flag in the chart that says "This patient needs imaging in three months." No notification to the patient. No scheduled appointment. The recommendation exists in the note, but there is no structural follow-through.
Providers don't document clear ownership of follow-up.
A provider might say "Follow up with me" or "Follow up in three months" without documenting: Who will call? When? What if the patient doesn't call? Is the patient expected to initiate, or will the provider? Without clear ownership, both the provider and patient assume the other will take action—and neither does.
COVID and other disruptions expose the fragility of vague plans.
A three-month follow-up plan might work if nothing intervenes. But office closures, scheduling delays, staff turnover, system crashes—any disruption reveals that the plan was never robust. If the plan depends entirely on the patient remembering and initiating follow-up, the plan is not a plan. It's a hope.
Good providers understand that watch-and-wait requires structure.
A truly competent provider says: "I recommend monitoring this. Here's what that means: You will return in three months for repeat imaging. I am scheduling that appointment today. You will receive a reminder email two weeks before your appointment. If your symptoms change before three months, call me immediately. Here's my number." They document the plan. They schedule the follow-up. They create structure.
But many providers—even good ones, facing time pressure and system limitations—give vague recommendations and move on. And when disease progresses in the gap, the damage is done.
This is a system design problem. But it costs you health.
CLUE™ is how you recognize when watch-and-wait lacks a plan and how you demand specificity.
The signal appears when a provider recommends monitoring or follow-up without specifying when, how, or by whom.
You'll recognize it by:
· Provider tells you to "follow up" but doesn't schedule an appointment
· You're told to return "in three months" but no date is set
· Provider says "watch and wait" without documenting what that means
· You're told to contact the provider "if symptoms change" but no clear definition of what changes warrant contact
· No repeat testing schedule is documented
· No written plan is provided
· You leave without clarity on the next step
· Provider doesn't explain what symptoms would warrant urgent contact
· Provider doesn't state whether they will contact you or you should contact them
· Months pass with no follow-up contact from the provider
A dismissing provider says: "Follow up in three months."
A responsible provider says: "I'm scheduling your follow-up for exactly three months from today. You'll receive a reminder. Here's what we'll test. Here's who to call if symptoms change before then. Here's my direct contact number."
The difference is specificity.
Across your medical visits:
The pattern of undefined watch-and-wait means:
· Recommendations are vague
· No appointments are scheduled
· No written plan exists
· No clear timeline is set
· You're left uncertain about next steps
· Weeks or months pass with no contact
· Disease progresses in the gap
The pattern of defined watch-and-wait means:
· The plan is specific and documented
· Follow-up appointments are scheduled in advance
· Repeat testing dates are set
· You know exactly when to return
· You understand what symptoms warrant urgent contact
· You know how to reach your provider
· Follow-up happens as planned
The pattern reveals whether you're being monitored or left to drift.
The medical culture valorizes autonomy and patient choice. "You can have a biopsy now, or you can follow up in three months. Your choice." This sounds respectful. But it can be abdication of responsibility.
Providers are trained to offer options. But when one option is objectively safer (earlier diagnosis, less disease progression), the provider has a responsibility to recommend it or to ensure that the monitoring plan is robust.
A vague follow-up recommendation is not offering choice. It's avoiding commitment. It's leaving the patient to drift.
Women who maintain their health understand this early:
Watch-and-wait is only safe if the plan is defined. If you can't write down the plan, it's not a plan.
They don't accept vague recommendations. When a provider recommends monitoring, they ask:
· When exactly will I return?
· What test will be repeated?
· How will I be contacted?
· What symptoms warrant urgent contact?
· Is the appointment scheduled today?
They get the plan in writing. They document it. They confirm it before leaving the office. They understand that a defined plan is not optional—it is the minimum standard of care for any monitoring strategy.
This understanding is embedded in the USU framework: Watch-and-wait is acceptable only with a defined, documented plan. If you can't write it down, don't do it.
Watch-and-wait can be appropriate medicine. Slow-growing cancers, benign-appearing findings, situations where early intervention carries risk—these are legitimate reasons to monitor rather than treat.
But appropriate monitoring is not the same as vague drifting.
Here's what matters: When a provider recommends watching and waiting, a plan must exist. Not a suggestion. A plan. When the patient will return. What testing will be repeated. What symptoms warrant urgent contact. How the patient will be reached. Who owns the follow-up.
Providers who understand this schedule the appointment before the patient leaves. They document the plan in the chart. They send the patient a written summary. They create a system to ensure follow-up actually happens.
But many providers, facing time pressure and system limitations, give vague recommendations and assume the patient will initiate follow-up. And when months pass and disease progresses, the responsibility falls on the patient—who was told to wait but was never told how long, who was told to return but was never told when, who was told to monitor but was never told what they were monitoring for.
You deserve better. You deserve a plan.
Prior normal tests used to dismiss new symptoms. You had normal bloodwork last year. This year you're developing new symptoms. The provider says: "Your labs were normal. I'm sure you're fine." The old test becomes permission to ignore the new symptom. The normal result from months ago becomes an excuse not to investigate what's happening now.
Stay aware. Stay ready. Stay impossible to dismiss.
— USU
Next week: Issue #22
Prior normal tests used to dismiss new symptoms. When yesterday's "normal" becomes an excuse not to investigate today's changes.
The Unusual Symptom Unit Podcast — Coming Summer 2026
High-production case file investigations into the medical cases that fall through the cracks. Real frameworks you can use now. Real cases coming soon.
The Hybrid Journal — Waitlist Open
Your symptoms live in your body. Your records live in five different portals. That gap costs women critical time. The journal I'm building closes it—SDI™ tracking with carbon copy pages for your doctor, portal navigation tools, and space to own your full health story. Be the first to know when the waitlist is open by sending an email to: info@cw-alliance.com.
P.S. Watch-and-wait without a defined plan is not medicine—it's abandonment. Demand specificity. Demand a timeline. Demand a plan you can write down.
About USU Dispatch: Weekly investigative health intel from the Unusual Symptom Unit. This dispatch series examines the thirty patterns between unusual symptoms and medical dismissal. The podcast—launching Summer 2026—will investigate the cases, the women, and the solutions.
Subscribe to USU Dispatch™
Weekly investigative health intel that helps you document clearly, speak with precision, and become impossible to dismiss in the medical system.
USU Dispatch™
Intelligence for women navigating medical uncertainty
© CW Alliance, LLC